Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Puerta de Hierro (7)

2023

  1. Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity

    Clinical and Translational Oncology, Vol. 25, Núm. 11, pp. 3073-3085

  2. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

2022

  1. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing

    PLoS ONE, Vol. 17, Núm. 2 February

  2. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2020

  1. First national registry on the effectiveness and safety of evolocumab in clinical practice in patients attended in cardiology in Spain. The RETOSS-CARDIO study

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 6, pp. 231-241

2016

  1. Selección de temas de actualidad en cardiología clínica, cardiología geriátrica e insuficiencia cardiaca y trasplante 2015

    Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 159-166

2015

  1. Update for 2014 on clinical cardiology, geriatric cardiology, and heart failure and transplantation

    Revista Espanola de Cardiologia, Vol. 68, Núm. 4, pp. 317-323